# Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure

> **NCT05111769** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Recombinant human brain natriuretic peptide

## Key facts

- **NCT ID:** NCT05111769
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2021-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111769, "Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05111769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*